# ![@ASX_IHL Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::1075579982523424769.png) @ASX_IHL Incannex Healthcare Inc.

Incannex Healthcare Inc. posts on X about $ihl, $ixhl, nasdaq, $ixhls the most. They currently have [-----] followers and [---] posts still getting attention that total [-----] engagements in the last [--] hours.

### Engagements: [-----] [#](/creator/twitter::1075579982523424769/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1075579982523424769/c:line/m:interactions.svg)

- [--] Week [-----] +58%
- [--] Month [------] +58%
- [--] Months [-------] -8.80%
- [--] Year [-------] +111,183%

### Mentions: [--] [#](/creator/twitter::1075579982523424769/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1075579982523424769/c:line/m:posts_active.svg)

- [--] Week [--] no change
- [--] Month [--] +25%
- [--] Months [--] +81%
- [--] Year [--] +1,850%

### Followers: [-----] [#](/creator/twitter::1075579982523424769/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1075579982523424769/c:line/m:followers.svg)

- [--] Week [-----] +0.49%
- [--] Month [-----] +0.95%
- [--] Months [-----] +30%
- [--] Year [-----] +276%

### CreatorRank: [-------] [#](/creator/twitter::1075579982523424769/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1075579982523424769/c:line/m:influencer_rank.svg)

### Social Influence

**Social category influence**
[exchanges](/list/exchanges)  44.12% [finance](/list/finance)  11.76% [travel destinations](/list/travel-destinations)  3.92% [countries](/list/countries)  3.92% [technology brands](/list/technology-brands)  0.98%

**Social topic influence**
[$ihl](/topic/$ihl) 63.73%, [$ixhl](/topic/$ixhl) #1, [nasdaq](/topic/nasdaq) 44.12%, [$ixhls](/topic/$ixhls) 10.78%, [ceo](/topic/ceo) 6.86%, [in the](/topic/in-the) 4.9%, [listing](/topic/listing) 3.92%, [share](/topic/share) 3.92%, [check](/topic/check) 2.94%, [melbourne](/topic/melbourne) 2.94%

**Top accounts mentioned or mentioned by**
[@tikcric](/creator/undefined) [@nasdaq](/creator/undefined) [@stockhead](/creator/undefined) [@asxihl](/creator/undefined) [@gohealio](/creator/undefined) [@benmcomer](/creator/undefined) [@ceovaliant](/creator/undefined) [@drugdiscovnews](/creator/undefined) [@monashtrauma](/creator/undefined) [@cnbc](/creator/undefined) [@smh](/creator/undefined) [@abcnews](/creator/undefined) [@channel9](/creator/undefined) [@australian](/creator/undefined) [@aasmorg](/creator/undefined) [@researchsleep](/creator/undefined) [@sleepfoundation](/creator/undefined) [@drugresearcher](/creator/undefined) [@psychedelicmed](/creator/undefined) [@psychedalpha](/creator/undefined)
### Top Social Posts
Top posts by engagements in the last [--] hours

"In a recent interview with @CeoValiant $IXHL's President & CEO Joel Latham shared insights on building resilient teams navigating market volatility and leading with clarity and discipline during times of uncertainty. Read the full Q&A here: https://valiantceo.com/resilient-leadership-insights-from-joel-latham-of-incannex-healthcare/ https://valiantceo.com/resilient-leadership-insights-from-joel-latham-of-incannex-healthcare/"  
[X Link](https://x.com/ASX_IHL/status/2017298235363365126)  2026-01-30T18:05Z [----] followers, [----] engagements


"$IXHL announces the appointment of [--] additional members to its Clinical Advisory Board providing further independent clinical & scientific guidance as the company progresses PSX-001 into its next phase of clinical & regulatory development. Read more: https://bit.ly/4brR02c https://bit.ly/4brR02c"  
[X Link](https://x.com/ASX_IHL/status/2016870514061647976)  2026-01-29T13:46Z [----] followers, [----] engagements


".@DrugDiscovNews' Dr. Bree Foster covers how #psychedelictherapeutics are shifting from the experimental research phases to more recognized opportunities in mental health care. Check out her coverage here which includes comments from our President and CEO Joel Latham: https://bit.ly/46xY35Q https://bit.ly/46xY35Q"  
[X Link](https://x.com/ASX_IHL/status/2021583837323731429)  2026-02-11T13:55Z [----] followers, [----] engagements


"$IXHL is dedicated to developing and delivering innovative medicines for those that have chronic diseases with unmet needs. #IncannexHealthcare encourages physicians and patients interested in our investigational therapy #clinicaltrials to visit our site: https://bit.ly/4mvpKlJ https://bit.ly/4mvpKlJ"  
[X Link](https://x.com/ASX_IHL/status/2022020413673361509)  2026-02-12T18:50Z [----] followers, [----] engagements


"$IHL Incannex Healthcare #ASX announcement: appoints EAS Advisors to facilitate introductions to US institutions with the intention to list on a US main market due to deep investor interest in #FDA #medcan and #psychedelic endeavors. Link here: https://stocknessmonster.com/announcements/ihl.asx-3A561000/ https://stocknessmonster.com/announcements/ihl.asx-3A561000/"  
[X Link](https://x.com/ASX_IHL/status/1359658985129840641)  2021-02-11T00:22Z [----] followers, [--] engagements


"$IHL Incannex Healthcare #ASX Announcement: IHL-675A demonstrated to outperform #CBD for anti-inflammatory properties in a pre-clinical study of #IBD; potential for IHL-675A to become a multi-use medication #ARDS #COPD #Asthma Link here: https://stocknessmonster.com/announcements/ihl.asx-3A561303/ https://stocknessmonster.com/announcements/ihl.asx-3A561303/"  
[X Link](https://x.com/ASX_IHL/status/1361463119864754181)  2021-02-15T23:51Z [----] followers, [--] engagements


"$IHL Incannex Healthcare #ASX Announcement: Incannex partners with the @MonashTrauma Group to conduct a study into the neuroprotective capability of IHL-216A - using a model previously co-developed by the #NFL to mimic player #concussion. Link here: https://stocknessmonster.com/announcements/ihl.asx-3A563317/ https://stocknessmonster.com/announcements/ihl.asx-3A563317/"  
[X Link](https://x.com/ASX_IHL/status/1369798683428941829)  2021-03-10T23:53Z [----] followers, [--] engagements


"$IHL Incannex Healthcare #ASX Announcement: IHL-675A outperforms existing treatment (#plaquenil) for #rheumatoid #arthritis in vivo. #Incannex initiates sixth clinical program for its development. #ausbiz #biotech Link here: https://stocknessmonster.com/announcements/ihl.asx-3A563594/ https://stocknessmonster.com/announcements/ihl.asx-3A563594/"  
[X Link](https://x.com/ASX_IHL/status/1371601884243398656)  2021-03-15T23:19Z [----] followers, [--] engagements


"$IHL Incannex Healthcare #ASX media article (#ausbiz #biotech #FDA #CBD #cannabidiol): https://stockhead.com.au/health/incannex-granted-meeting-with-fda-over-cbd-drug-cocktail/ https://stockhead.com.au/health/incannex-granted-meeting-with-fda-over-cbd-drug-cocktail/"  
[X Link](https://x.com/ASX_IHL/status/1375253531767107584)  2021-03-26T01:09Z [----] followers, [--] engagements


"$IHL #ASX announcement: Positive #FDA Pre-IND meeting guides IHL-675A development plan. Incannex expands its program to assesses potential for IHL-675A to become a multi-use #pharmaceutical drug. #cbd #ausbiz Link here: https://www.asx.com.au/asxpdf/20210422/pdf/44vrdh63y8dl0h.pdf https://www.asx.com.au/asxpdf/20210422/pdf/44vrdh63y8dl0h.pdf"  
[X Link](https://x.com/ASX_IHL/status/1385003433183244289)  2021-04-21T22:52Z [----] followers, [---] engagements


"$IHL Incannex Healthcare #ASX media article: https://stockhead.com.au/health/incannex-gets-more-good-news-as-fda-approves-expanded-development-pathway-for-its-ihl-675-treatment/ https://stockhead.com.au/health/incannex-gets-more-good-news-as-fda-approves-expanded-development-pathway-for-its-ihl-675-treatment/"  
[X Link](https://x.com/ASX_IHL/status/1385061997675356160)  2021-04-22T02:44Z [----] followers, [--] engagements


"$IHL Incannex Healthcare Ltd #ASX March [----] quarterly activities report and appendix 4C. Link here: #asxnews #ausbiz #biotech #FDA #CBD #psychedelic https://www.asx.com.au/asxpdf/20210429/pdf/44vz6m74tf5pry.pdf https://www.asx.com.au/asxpdf/20210429/pdf/44vz6m74tf5pry.pdf"  
[X Link](https://x.com/ASX_IHL/status/1387572886932647938)  2021-04-29T01:02Z [----] followers, [--] engagements


"$IHL #ASX announce: Incannex partners with UWA to uprate the IHL-42X clinical trial to a multi-site study Patient recruitment at UWA running in parallel with The Alfred Hospital in Melbourne where the trial is underway. #asxnews #ausbiz Link here: https://www.asx.com.au/asxpdf/20210511/pdf/44wd2xr39ygpm3.pdf https://www.asx.com.au/asxpdf/20210511/pdf/44wd2xr39ygpm3.pdf"  
[X Link](https://x.com/ASX_IHL/status/1391897956257656833)  2021-05-10T23:28Z [----] followers, [--] engagements


"$IHL #ASX announce: Incannex appoints inhalation specialists Vectura Ltd to manufacture IHL-216A for use in clinical trials. IHL-216A is designed for use after #concussion to reduce secondary brain injuries. #asxnews #ausbiz #FDA #CBD Link here: https://www.asx.com.au/asxpdf/20210621/pdf/44xjmgdddcmp5l.pdf https://www.asx.com.au/asxpdf/20210621/pdf/44xjmgdddcmp5l.pdf"  
[X Link](https://x.com/ASX_IHL/status/1406753293271912450)  2021-06-20T23:18Z [----] followers, [--] engagements


"$IHL Incannex Healthcare #ASX media article (#asxnews #ausbiz #biotech #FDA): https://stockhead.com.au/health/why-this-hidden-gem-in-the-incannex-product-suite-could-be-a-global-market-winner/ https://stockhead.com.au/health/why-this-hidden-gem-in-the-incannex-product-suite-could-be-a-global-market-winner/"  
[X Link](https://x.com/ASX_IHL/status/1407863260150341632)  2021-06-24T00:48Z [----] followers, [--] engagements


"$IHL #ASX announce: Incannex engages Procaps to manufacture IHL-675A soft gel capsules. IHL-675A is being assessed as a multi-use drug applicable to lung inflammation #arthritis and #IBD. #asxnews #ausbiz #FDA #CBD Link here: https://www.asx.com.au/asxpdf/20210716/pdf/44ycdqk4w7bwt0.pdf https://www.asx.com.au/asxpdf/20210716/pdf/44ycdqk4w7bwt0.pdf"  
[X Link](https://x.com/ASX_IHL/status/1415809742702743554)  2021-07-15T23:05Z [----] followers, [--] engagements


"$IHL #ASX ann: Incannex files international patent application over IHL-42X; receives ethic's approval to extend delivery of IHL-42X to patients in an open label study. Phase 2b clinical trial results expected Q4 CY2021. #asxnews #FDA #apnea Read here: https://www.asx.com.au/asxpdf/20210722/pdf/44yjq8mz0scn8q.pdf https://www.asx.com.au/asxpdf/20210722/pdf/44yjq8mz0scn8q.pdf"  
[X Link](https://x.com/ASX_IHL/status/1417997687559884805)  2021-07-21T23:59Z [----] followers, [--] engagements


"$IHL Incannex Healthcare #ASX media article (#asxnews #ausbiz #biotech #fda #CBD #incannex) https://stockhead.com.au/health/incannex-files-global-patent-for-its-ihl-42x-sleep-apnoea-treatment-and-receives-ethics-approval-to-administer-to-patients-every-day-in-an-extension-trial/ https://stockhead.com.au/health/incannex-files-global-patent-for-its-ihl-42x-sleep-apnoea-treatment-and-receives-ethics-approval-to-administer-to-patients-every-day-in-an-extension-trial/"  
[X Link](https://x.com/ASX_IHL/status/1418360416313376770)  2021-07-23T00:00Z [----] followers, [--] engagements


"$IHL Incannex Healthcare #ASX announcement: Incannex commences phase [--] clinical trial for multi-use drug candidate IHL-675A; patent application labelled "novel and inventive" by international patent examiner. #asxnews #ausbiz #FDA #CBD Read here: https://www.asx.com.au/asxpdf/20210727/pdf/44ynq0bdpwld4k.pdf https://www.asx.com.au/asxpdf/20210727/pdf/44ynq0bdpwld4k.pdf"  
[X Link](https://x.com/ASX_IHL/status/1419791788005494784)  2021-07-26T22:48Z [----] followers, [--] engagements


"$IHL Incannex Healthcare #ASX media article (#asxnews #ausbiz #biotech #FDA #CBD #incannex): https://stockhead.com.au/health/incannex-kicks-off-phase-1-clinical-trial-for-its-anti-inflammatory-treatment/ https://stockhead.com.au/health/incannex-kicks-off-phase-1-clinical-trial-for-its-anti-inflammatory-treatment/"  
[X Link](https://x.com/ASX_IHL/status/1419817832729047040)  2021-07-27T00:32Z [----] followers, [--] engagements


"$IHL Incannex Healthcare Ltd #ASX June [----] quarterly activities report and appendix 4C. Read here: #asxnews #ausbiz #biotech #FDA #CBD #psychedelics https://www.asx.com.au/asxpdf/20210730/pdf/44yt8mj9kqhtk0.pdf https://www.asx.com.au/asxpdf/20210730/pdf/44yt8mj9kqhtk0.pdf"  
[X Link](https://x.com/ASX_IHL/status/1420875790619582466)  2021-07-29T22:36Z [----] followers, [--] engagements


"$IHL Incannex Healthcare #ASX announcement: Incannex submits FDA PRE-IND meeting request and HREC proposal for "Psi-GAD" #Psilocybin psychotherapy therapy for generalised anxiety disorder #asxnews #ausbiz #FDA #psychedelics. Read here: https://www.asx.com.au/asxpdf/20210810/pdf/44z4yw8jpz3fwf.pdf https://www.asx.com.au/asxpdf/20210810/pdf/44z4yw8jpz3fwf.pdf"  
[X Link](https://x.com/ASX_IHL/status/1424862073817755652)  2021-08-09T22:36Z [----] followers, [--] engagements


"$IHL #ASX presentation of Incannex Psychedelic Therapies a subsidiary of Incannex Healthcare Ltd. Psi-GAD clinical development overview August [----]. #Psilocybin and psychotherapy for the treatment of Generalised Anxiety Disorder. Download here: https://www.asx.com.au/asxpdf/20210811/pdf/44z64h9fkjs2p1.pdf https://www.asx.com.au/asxpdf/20210811/pdf/44z64h9fkjs2p1.pdf"  
[X Link](https://x.com/ASX_IHL/status/1425227110772211712)  2021-08-10T22:46Z [----] followers, [--] engagements


"$IHL Incannex Healthcare #ASX announcement: Incannex files Form F-1 registration statement with the SEC for proposed initial public offering in the United States on Nasdaq #asxnews. Read here: https://www.asx.com.au/asxpdf/20210818/pdf/44zf2dsq4d60x5.pdf https://www.asx.com.au/asxpdf/20210818/pdf/44zf2dsq4d60x5.pdf"  
[X Link](https://x.com/ASX_IHL/status/1427769973913444356)  2021-08-17T23:11Z [----] followers, [--] engagements


"$IHL Incannex healthcare #asx media article (#asxnews #ausbiz #biotech #fda #psilocybin #psychedelics #incannex): https://stockhead.com.au/health/incannex-sets-sights-on-us-capital-markets-and-prepares-for-a-nasdaq-listing/ https://stockhead.com.au/health/incannex-sets-sights-on-us-capital-markets-and-prepares-for-a-nasdaq-listing/"  
[X Link](https://x.com/ASX_IHL/status/1429943721617879052)  2021-08-23T23:08Z [----] followers, [--] engagements


"$IHL #ASX #asxnews: Incannex engages Procaps to manufacture IHL-42X soft gel capsules as phase [--] clinical trial in patients with #sleepapnea advances. IHL-42X is being clinically evaluated as a pharmaceutical alternative to #CPAP device. Read here: https://www.asx.com.au/asxpdf/20211020/pdf/451vhzvy9vzzk1.pdf https://www.asx.com.au/asxpdf/20211020/pdf/451vhzvy9vzzk1.pdf"  
[X Link](https://x.com/ASX_IHL/status/1450585483617071104)  2021-10-19T22:11Z [----] followers, [--] engagements


"$IHL Incannex Healthcare announcement: Positive pre-IND meeting with US FDA and ethics approval to commence phase 2a Psi-GAD clinical trial: #Psilocybin-assisted psychotherapy for Generalised Anxiety Disorder. #ASX #asxnews Read here: https://www.asx.com.au/asxpdf/20211028/pdf/45274kkz97514l.pdf https://www.asx.com.au/asxpdf/20211028/pdf/45274kkz97514l.pdf"  
[X Link](https://x.com/ASX_IHL/status/1453491101885603845)  2021-10-27T22:37Z [----] followers, [--] engagements


"$IHL Incannex Healthcare announcement: update on Nasdaq initial public offering in the United States #psychedelic #psilocybin #cbd #thc #fda #biotech #nasdaq #ASX #asxnews Read here: https://www.asx.com.au/asxpdf/20211217/pdf/4548qnsrmjfy30.pdf https://www.asx.com.au/asxpdf/20211217/pdf/4548qnsrmjfy30.pdf"  
[X Link](https://x.com/ASX_IHL/status/1471613158833864704)  2021-12-16T22:48Z [----] followers, [--] engagements


"$IHL Incannex Healthcare announcement: Incannex completes dosing patients in phase [--] clinical trial of IHL-42X for obstructive sleep apnoea (#OSA) - prepares for #FDA Pre-IND meeting #cbd #thc #biotech #nasdaq #ASX #asxnews Read here: https://stocknessmonster.com/announcements/ihl.asx-3A584157/ https://stocknessmonster.com/announcements/ihl.asx-3A584157/"  
[X Link](https://x.com/ASX_IHL/status/1472695742846275585)  2021-12-19T22:30Z [----] followers, [--] engagements


"$IHL Incannex Healthcare media article: Incannex completes phase [--] trial for its cannabinoid drug for #sleepapnea flags Nasdaq listing in January [----] (#asx #asxnews #nasdaq #ausbiz #biotech #fda #cbd #thc #psilocybin #psychedelics #incannex) https://stockhead.com.au/health/incannex-completes-phase-2-trial-for-its-cannabinoid-drug-for-sleep-apnea-flags-nasdaq-listing-in-january-2022/ https://stockhead.com.au/health/incannex-completes-phase-2-trial-for-its-cannabinoid-drug-for-sleep-apnea-flags-nasdaq-listing-in-january-2022/"  
[X Link](https://x.com/ASX_IHL/status/1472770912835440642)  2021-12-20T03:28Z [----] followers, [--] engagements


"$IHL Incannex Healthcare Ltd #ASX December [----] quarterly activities report and appendix 4C. Read here: #CBD #THC #psilocybin #psychedelics #biotech #FDA #TGA #asxnews #ausbiz https://www.asx.com.au/asxpdf/20220131/pdf/455h8jjk6nf2cj.pdf https://www.asx.com.au/asxpdf/20220131/pdf/455h8jjk6nf2cj.pdf"  
[X Link](https://x.com/ASX_IHL/status/1487995462724747265)  2022-01-31T03:45Z [----] followers, [--] engagements


"$IHL $IXHL Incannex Healthcare is delighted to report that #incannex will be ringing the closing bell in Times Square to honour its @Nasdaq listing today Feb [--] [----] 3:45pm (US EST). The ceremony may be viewed here: #cbd #thc #Psilocybin #ASX #NASDAQ https://livestream.com/nasdaqmedia/events/10011858 https://livestream.com/nasdaqmedia/events/10011858"  
[X Link](https://x.com/ASX_IHL/status/1497282923158192128)  2022-02-25T18:50Z [----] followers, [---] engagements


"$IHL $IXHL Incannex Healthcare ringing the @Nasdaq closing bell as broadcast on @CNBC (#asx #nasdaq #biotech #fda #cbd #thc #psilocybin #psychedelics #incannex): Stocks climbed Friday to close out a volatile week of trading as investors continued to assess the financial risks stemming from Russias invasion of Ukraine. The Dow surged 2.51%. The S&P [---] rose 2.24%. The Nasdaq gained 1.64%. https://t.co/4Q61JknCsc https://t.co/g2stctYP2t Stocks climbed Friday to close out a volatile week of trading as investors continued to assess the financial risks stemming from Russias invasion of Ukraine."  
[X Link](https://x.com/ASX_IHL/status/1497350929490022400)  2022-02-25T23:20Z [----] followers, [--] engagements


"$IHL $IXHL Incannex Healthcare announcement: Incannex completes listing of American Depositary Shares on @Nasdaq and rings the Friday closing bell. #asx #asxnews #nasdaq #fda #cbd #thc #psilocybin #psychedelics #biotech #incannex Read here: https://www.asx.com.au/asxpdf/20220228/pdf/456gxmzd02l4ph.pdf https://www.asx.com.au/asxpdf/20220228/pdf/456gxmzd02l4ph.pdf"  
[X Link](https://x.com/ASX_IHL/status/1498057854552768512)  2022-02-27T22:09Z [----] followers, [--] engagements


"$IHL $IXHL #Incannex Healthcare announcement: License agreement with Monash University to facilitate the development of a leading-edge treatment for #anxiety that combines VR exposure therapy during #psychedelic experiences. Read here: #asx #nasdaq https://www.asx.com.au/asxpdf/20220303/pdf/456nfsx1cz1cbc.pdf https://www.asx.com.au/asxpdf/20220303/pdf/456nfsx1cz1cbc.pdf"  
[X Link](https://x.com/ASX_IHL/status/1499160734504460288)  2022-03-02T23:12Z [----] followers, [--] engagements


"$IHL(#ASX) $IXHL(#NASDAQ) Incannex Healthcare @stockhead media article. Incannex and Monash University to collaborate on ground-breaking research. #psychedelics #biotech #fda https://stockhead.com.au/health/no-worries-severe-anxiety-disorders-to-get-the-incannex-monash-uni-treatment-via-psychedelics-within-virtual-reality/ https://stockhead.com.au/health/no-worries-severe-anxiety-disorders-to-get-the-incannex-monash-uni-treatment-via-psychedelics-within-virtual-reality/"  
[X Link](https://x.com/ASX_IHL/status/1499256906833367041)  2022-03-03T05:34Z [----] followers, [--] engagements


"$IHL $IXHL announcement: #Incannex observes substantial reduction in AHI (up to 91.5%) in preliminary results of clinical trial assessing IHL-42X in patients with OSA; proceeds to #FDA pre-IND meeting. Read here: #asx #nasdaq #cbd #thc #psychedelics https://www.asx.com.au/asxpdf/20220310/pdf/456wc6s418rdhc.pdf https://www.asx.com.au/asxpdf/20220310/pdf/456wc6s418rdhc.pdf"  
[X Link](https://x.com/ASX_IHL/status/1501693279678910467)  2022-03-09T22:55Z [----] followers, [--] engagements


"$IHL (#ASX) $IXHL (#Nasdaq) Incannex Healthcare @stockhead media article. Positive IHL-42X clinical trial results; proceeding to pre-IND meeting with #FDA. https://stockhead.com.au/health/the-only-game-in-town-incannex-announces-big-clinical-trial-results-ihl-42x-drug-reduced-key-obstructive-sleep-apnoea-diagnostic-measure-by-up-to-91-5/ https://stockhead.com.au/health/the-only-game-in-town-incannex-announces-big-clinical-trial-results-ihl-42x-drug-reduced-key-obstructive-sleep-apnoea-diagnostic-measure-by-up-to-91-5/"  
[X Link](https://x.com/ASX_IHL/status/1501812807779909635)  2022-03-10T06:50Z [----] followers, [--] engagements


"$IHL $IXHL announcement: #Incannex to issue loyalty options to eligible shareholders and American depository shareholders. Read here: #asx #nasdaq #cbd #thc #psychedelics https://www.asx.com.au/asxpdf/20220318/pdf/4574d9n2hy2yv4.pdf https://www.asx.com.au/asxpdf/20220318/pdf/4574d9n2hy2yv4.pdf"  
[X Link](https://x.com/ASX_IHL/status/1504615784274075649)  2022-03-18T00:28Z [----] followers, [--] engagements


"$IHL $IXHL announcement: #Incannex to acquire pharmaceutical cannabinoid company APIRx Pharmaceuticals LLC. APIRx has [--] active clinical and pre-clinical R&D projects underpinned by [--] granted and [--] pending patents. Read here: #asx #nasdaq #cbd #thc https://www.asx.com.au/asxpdf/20220324/pdf/4579pbgxbtchjh.pdf https://www.asx.com.au/asxpdf/20220324/pdf/4579pbgxbtchjh.pdf"  
[X Link](https://x.com/ASX_IHL/status/1506764116077453314)  2022-03-23T22:45Z [----] followers, [--] engagements


"$IHL (#ASX) $IXHL (#Nasdaq) Incannex Healthcare @stockhead media article: "#Incannex secures landmark deal reinforcing position as a global medicinal cannabis and psychedelic powerhouse" https://stockhead.com.au/health/incannex-secures-landmark-deal-reinforcing-position-as-a-global-medicinal-cannabis-and-psychedelic-powerhouse/ https://stockhead.com.au/health/incannex-secures-landmark-deal-reinforcing-position-as-a-global-medicinal-cannabis-and-psychedelic-powerhouse/"  
[X Link](https://x.com/ASX_IHL/status/1506856512555466752)  2022-03-24T04:52Z [----] followers, [--] engagements


"$IHL (#ASX) $IXHL (#NASDAQ) Incannex Healthcare Ltd March [----] quarterly activities report and appendix 4C. Company adequately funded with $40m in cash and no debt. Activities report serves as company snapshot. Read here: #CBD #THC #psychedelics #FDA https://www.asx.com.au/asxpdf/20220428/pdf/458cxpwfhj109r.pdf https://www.asx.com.au/asxpdf/20220428/pdf/458cxpwfhj109r.pdf"  
[X Link](https://x.com/ASX_IHL/status/1519452282814799872)  2022-04-27T23:03Z [----] followers, [--] engagements


"$IHL (#ASX) $IXHL Incannex Healthcare @stockhead media article: "#Incannex had a busy quarter of clinical research breakthroughs listing on #NASDAQ and making a play for a #cannabinoid development company with a big patent portfolio. https://stockhead.com.au/health/with-40m-in-the-bank-and-an-exciting-product-suite-incannex-targets-game-changing-us-acquisition-for-even-more-growth/ https://stockhead.com.au/health/with-40m-in-the-bank-and-an-exciting-product-suite-incannex-targets-game-changing-us-acquisition-for-even-more-growth/"  
[X Link](https://x.com/ASX_IHL/status/1519527688918429698)  2022-04-28T04:03Z [----] followers, [--] engagements


"$IHL $IXHL #incannex announcement: IHL-216A observed to have a neuroprotective effect in rodent model of sports concussion; rapidly restores spatial memory post-concussion. Read here: #asx #nasdaq #cbd #biotech https://www.asx.com.au/asxpdf/20220510/pdf/458vm1xf226x2t.pdf https://www.asx.com.au/asxpdf/20220510/pdf/458vm1xf226x2t.pdf"  
[X Link](https://x.com/ASX_IHL/status/1523811807026348032)  2022-05-09T23:47Z [----] followers, [--] engagements


"$IHL (#ASX) $IXHL (#nasdaq) #Incannex completes share sale and purchase agreement to wholly acquire APIRx Pharmaceuticals to create world's largest portfolio of patented medicinal cannabinoid drug candidates (#cbd #thc #fda #biotech). Presentation here: https://www.asx.com.au/asxpdf/20220512/pdf/458xyg99xxbh01.pdf https://www.asx.com.au/asxpdf/20220512/pdf/458xyg99xxbh01.pdf"  
[X Link](https://x.com/ASX_IHL/status/1524536824840224768)  2022-05-11T23:47Z [----] followers, [--] engagements


"$IHL (#ASX) $IXHL (#nasdaq) #Incannex announcement: Positive pre-IND meeting with US #FDA for IHL-42X (cannabinoid combination drug) for Obstructive Sleep Apnoea. #cbd #thc #sleepapnea #cpap #biotech Read here: https://www.asx.com.au/asxpdf/20220517/pdf/4591w49hhk2rgw.pdf https://www.asx.com.au/asxpdf/20220517/pdf/4591w49hhk2rgw.pdf"  
[X Link](https://x.com/ASX_IHL/status/1526350059142791169)  2022-05-16T23:53Z [----] followers, [--] engagements


"$IHL (#ASX) $IXHL (#nasdaq) #Incannex announces positive final report regarding results from phase [--] clinical trial of IHL-42X for the treatment of Obstructive Sleep Apnoea. Major improvements in disease markers observed (#thc #fda). Presentation here: https://www.asx.com.au/asxpdf/20220603/pdf/459lkt8gzdphzd.pdf https://www.asx.com.au/asxpdf/20220603/pdf/459lkt8gzdphzd.pdf"  
[X Link](https://x.com/ASX_IHL/status/1532511279768039424)  2022-06-02T23:55Z [----] followers, [--] engagements


"$IHL (#ASX) $IXHL (#nasdaq) #Incannex shareholders at shareholder's meeting approve consideration for APRIRx Pharmaceuticals acquisition to be completed (#cbd #thc #fda #biotech). Meeting results: APIRx presentation: https://www.asx.com.au/asxpdf/20220512/pdf/458xyg99xxbh01.pdf https://www.asx.com.au/asxpdf/20220609/pdf/459sgvt9p17tt5.pdf https://www.asx.com.au/asxpdf/20220512/pdf/458xyg99xxbh01.pdf https://www.asx.com.au/asxpdf/20220609/pdf/459sgvt9p17tt5.pdf"  
[X Link](https://x.com/ASX_IHL/status/1534702544244846592)  2022-06-09T01:02Z [----] followers, [--] engagements


"$IHL (#ASX) $IXHL (#nasdaq) #Incannex announces that it has received ethics approval to commence a phase [--] clinical trial to assess multi-use anti-inflammatory drug IHL-675A. (#cbd #inflammation #biotech #fda) Read here: https://www.asx.com.au/asxpdf/20220721/pdf/45c17rz8v741h0.pdf https://www.asx.com.au/asxpdf/20220721/pdf/45c17rz8v741h0.pdf"  
[X Link](https://x.com/ASX_IHL/status/1549897814754611200)  2022-07-20T23:23Z [----] followers, [--] engagements


"$IHL (#ASX) $IXHL (#NASDAQ) Incannex Healthcare Ltd June [----] quarterly activities report and appendix 4C cash flow statement. Company adequately funded with $37.5M in cash for continued development actitivites. Read here: #CBD #THC #psychedelics #FDA https://www.asx.com.au/asxpdf/20220727/pdf/45c6pl8wp2gkbs.pdf https://www.asx.com.au/asxpdf/20220727/pdf/45c6pl8wp2gkbs.pdf"  
[X Link](https://x.com/ASX_IHL/status/1552079865582866432)  2022-07-26T23:54Z [----] followers, [--] engagements


"$IHL (#ASX) $IXHL (#nasdaq) #Incannex announces scale up of manufacture of neuroprotective drug IHL-216A following proof-of-concept in formulation development. Files another patent application. (#cbd #concussion #CTE #biotech #fda) Read here: https://www.asx.com.au/asxpdf/20220802/pdf/45cg9jz0cb5wwm.pdf https://www.asx.com.au/asxpdf/20220802/pdf/45cg9jz0cb5wwm.pdf"  
[X Link](https://x.com/ASX_IHL/status/1554244844490756097)  2022-08-01T23:17Z [----] followers, [--] engagements


"$IHL (#ASX) $IXHL (#nasdaq) #Incannex announces completion of the acquisition of APIRx Pharmaceuticals to aggregate the Worlds largest portfolio of patented medicinal cannabinoid drug formulations. (#cbd #thc #biotech #clinicaltrials #fda) Read here: https://www.asx.com.au/asxpdf/20220805/pdf/45ckrg01vbrgm1.pdf https://www.asx.com.au/asxpdf/20220805/pdf/45ckrg01vbrgm1.pdf"  
[X Link](https://x.com/ASX_IHL/status/1555339883556012032)  2022-08-04T23:48Z [----] followers, [--] engagements


"$IHL (#ASX) $IXHL (#nasdaq) media article: #Incannex completes landmark deal positioning as a global leader in medicinal cannabis and psychedelics. (#cbd #thc #biotech #clinicaltrials #fda) https://stockhead.com.au/health/apirx-dr-george-anastassov-patents-pharmaceutical/ https://stockhead.com.au/health/apirx-dr-george-anastassov-patents-pharmaceutical/"  
[X Link](https://x.com/ASX_IHL/status/1555400442720702464)  2022-08-05T03:48Z [----] followers, [--] engagements


"$IHL (#ASX) $IXHL (#nasdaq): Company overview summarising all major activities being undertaken at #Incannex. #cbd #thc #psychedelic #fda #biotech Presentation here: https://www.asx.com.au/asxpdf/20220809/pdf/45cnwncjjn1bq1.pdf https://www.asx.com.au/asxpdf/20220809/pdf/45cnwncjjn1bq1.pdf"  
[X Link](https://x.com/ASX_IHL/status/1556788156883963904)  2022-08-08T23:43Z [----] followers, [--] engagements


"$IHL (#ASX) $IXHL (#nasdaq) #Incannex announces the appointment of distiguished #FDA regulatory affairs expert Mr Robert (Bob) B Clark to the Board of Directors. Bob is amongst the best credentialed regulatory affairs experts in the world. Read here: https://www.asx.com.au/asxpdf/20220817/pdf/45cxl3l5t07jc0.pdf https://www.asx.com.au/asxpdf/20220817/pdf/45cxl3l5t07jc0.pdf"  
[X Link](https://x.com/ASX_IHL/status/1559666808868990976)  2022-08-16T22:21Z [----] followers, [--] engagements


"$IHL (#ASX) $IXHL (#NASDAQ) media article: Power move: #Incannex attracts global regulatory affairs expert to the board - to help steer #FDA regulatory approvals for its #cannabinoid (#cbd #thc) medicines and #psychedelic therapies. https://stockhead.com.au/health/power-move-incannex-attracts-global-regulatory-affairs-expert-novo-nordisk-exec-to-board/ https://stockhead.com.au/health/power-move-incannex-attracts-global-regulatory-affairs-expert-novo-nordisk-exec-to-board/"  
[X Link](https://x.com/ASX_IHL/status/1559806370295447552)  2022-08-17T07:36Z [----] followers, [--] engagements


"$IHL (#ASX) $IXHL (#nasdaq) #Incannex completes positive pre-IND meeting with the U.S. #FDA on IHL-216A for the treatment of traumatic brain injury (#tbi) and #concussion. (#CBD #biotech #WADA) Read here: https://www.asx.com.au/asxpdf/20221011/pdf/45g45tpf90w61n.pdf https://www.asx.com.au/asxpdf/20221011/pdf/45g45tpf90w61n.pdf"  
[X Link](https://x.com/ASX_IHL/status/1579598846057140224)  2022-10-10T22:24Z [----] followers, [--] engagements


"$IHL (#ASX) $IXHL (#nasdaq) #Incannex observes no adverse events of concern to date in Phase [--] clinical trial to assess multi-use anti-inflammatory drug IHL-675A and proceeds to Phase [--] studies. (#FDA #CBD #arthritis #IBD #lung #inflammation) Read here: https://www.asx.com.au/asxpdf/20221013/pdf/45g6znccf774b0.pdf https://www.asx.com.au/asxpdf/20221013/pdf/45g6znccf774b0.pdf"  
[X Link](https://x.com/ASX_IHL/status/1580328512770125825)  2022-10-12T22:44Z [----] followers, [--] engagements


"$IHL (#ASX) $IXHL (#nasdaq) announces a development update for #medcan drug IHL-42X for Obstructive #sleepapnea. Once the #FDA IND is open Incannex will commence pivotal Phase 2/3 #clinicaltrials Read here: #cbd #thc #cannabis #biotech #cpap https://www.asx.com.au/asxpdf/20221117/pdf/45hpgxg96f6lfh.pdf https://www.asx.com.au/asxpdf/20221117/pdf/45hpgxg96f6lfh.pdf"  
[X Link](https://x.com/ASX_IHL/status/1593021092192735232)  2022-11-16T23:19Z [----] followers, [--] engagements


"$IHL (#ASX) $IXHL (#nasdaq) media article regarding changes from #TGA to allow #psilocybin and #mdma treatments in #Australia. The article touches on ramifications for the Incannex "Psi-GAD" #psilocybin #FDA development program designed to assist people with severe #anxiety. Australia leads the way as TGA allows psilocybin and MDMA for treating depression and PTSD https://t.co/PPisbwc59b #ASX $IHL @ASX_IHL Australia leads the way as TGA allows psilocybin and MDMA for treating depression and PTSD https://t.co/PPisbwc59b #ASX $IHL @ASX_IHL"  
[X Link](https://x.com/ASX_IHL/status/1622383450358706176)  2023-02-05T23:55Z [----] followers, [----] engagements


"$IHL (#ASX) $IXHL (#nasdaq) #ASXnews announcement: #Incannex commences [---] patient multi-site phase [--] #clinicaltrial assessing cannabinoid combination drug IHL-675A for treatment of pain and function in rheumatoid #arthritis. #CBD #FDA #TGA Read here: https://www.asx.com.au/asxpdf/20230228/pdf/45m4bb2qyyytr7.pdf https://www.asx.com.au/asxpdf/20230228/pdf/45m4bb2qyyytr7.pdf"  
[X Link](https://x.com/ASX_IHL/status/1630340011538391040)  2023-02-27T22:52Z [----] followers, [----] engagements


"$IHL (#ASX) $IXHL (#nasdaq) #ASXnews announcement: Interim review of #Incannex PsiGAD clinical trial data indicates no safety concerns and projects a statistically significant benefit for the #psilocybin arm versus the placebo arm in those participants who have completed the treatment for generalised #anxiety disorder Read here: #psychedelics #FDA #TGA #ausbiz https://asx.com.au/asxpdf/20230315/pdf/45mp7kwhgtk3k3.pdf https://asx.com.au/asxpdf/20230315/pdf/45mp7kwhgtk3k3.pdf"  
[X Link](https://x.com/ASX_IHL/status/1635968784346550272)  2023-03-15T11:38Z [----] followers, [----] engagements


"$IHL (#ASX) $IXHL (#nasdaq) announcement: Incannex appoints esteemed principal investigators to IHL-42X Phase 2/3 clinical trial in patients with obstructive #sleep #apnea. (#FDA #medicinalcannabis #ASXnews) Read here: https://announcements.asx.com.au/asxpdf/20230616/pdf/05qpw85gbjm5cg.pdf https://announcements.asx.com.au/asxpdf/20230616/pdf/05qpw85gbjm5cg.pdf"  
[X Link](https://x.com/ASX_IHL/status/1669476921577701376)  2023-06-15T22:48Z [----] followers, [----] engagements


"$IHL (#ASX) $IXHL (#nasdaq) announcement: Incannex receives ethics approval to commence bioequivalence/bioavailability clincial trial for IHL-42X a proprietary drug treatment for obstructive #sleep #apnea. (#FDA #medicinalcannabis #ASXnews) Read here: https://announcements.asx.com.au/asxpdf/20230706/pdf/05rccgd7lqhfx3.pdf https://announcements.asx.com.au/asxpdf/20230706/pdf/05rccgd7lqhfx3.pdf"  
[X Link](https://x.com/ASX_IHL/status/1676741120796262402)  2023-07-05T23:53Z [----] followers, [----] engagements


"$IHL (#ASX #ASXnews) $IXHL (#nasdaq) announcement: Incannex receives HREC approval for large scale Phase [--] clinical trial assessing IHL-675A for use in treatment of pain and function in Rheumatoid #Arthritis It follows Phase [--] and animal study observations of IHL-675A substantially reducing inflammatory disease scores to a greater extent than hydroxychloroquine a common long-standing prescription drug called #Plaquenil with a considerable market profile. Read here: (#FDA #biotech #cbd #thc #medcan) https://announcements.asx.com.au/asxpdf/20230713/pdf/05rlbxnlshhzrv.pdf"  
[X Link](https://x.com/ASX_IHL/status/1679271602238951424)  2023-07-12T23:28Z [----] followers, [----] engagements


"$IHL (#ASX) and $IXHL (#nasdaq) Announcement: Incannex completes positive pre-IND meeting with US FDA on IHL-675A for treatment of rheumatoid #arthritis (#FDA #CBD #THC #ASXnews) Read here: https://announcements.asx.com.au/asxpdf/20230726/pdf/05rywwh0zqgx20.pdf https://announcements.asx.com.au/asxpdf/20230726/pdf/05rywwh0zqgx20.pdf"  
[X Link](https://x.com/ASX_IHL/status/1683995247704158208)  2023-07-26T00:18Z [----] followers, [----] engagements


"$IHL (#ASX) and $IXHL (#nasdaq) announcement: Incannex subsidiary Clarion Clinics begins accepting registrations for #psychedelic treatment as part of pre-screening in readiness for opening. Clarion Clinics will provide #psilocybin assisted psychotherapy for treatment-resistant #depression and #MDMA assisted psychotherapy for #PTSD. First clinic in Abbotsford Melbourne nearing fit-out completion. Read announcement here: Clarion Clinics website: (#ASXnews @smh @abcnews @channel9 @australian) https://clarionclinics.com/ https://announcements.asx.com.au/asxpdf/20230808/pdf/05sf4dxpf06cd1.pdf"  
[X Link](https://x.com/ASX_IHL/status/1688683178012430343)  2023-08-07T22:46Z [----] followers, [----] engagements


"$IHL (#ASX) and $IXHL (#nasdaq) announcement: #FDA approves IND application for IHL-42X pivotal Phase 2/3 clinical trial for #sleepapnea to commence in the US. (#asxnews #sleep @AASMorg @researchsleep @sleepfoundation) Read here: https://announcements.asx.com.au/asxpdf/20230822/pdf/05sw4t4h7vmd2s.pdf https://announcements.asx.com.au/asxpdf/20230822/pdf/05sw4t4h7vmd2s.pdf"  
[X Link](https://x.com/anyuser/status/1693767672750870920)  2023-08-21T23:30Z [----] followers, [----] engagements


"$IHL (#ASX #ASXnews) and $IXHL (#nasdaq) announcement: Incannex to prepare #FDA IND application for #psilocybin-assisted #psychedelic psychotherapy program for #anxiety known as Psi-GAD. Nears completion of inital [--] person Phase [--] trial at Monash University. Interim statistical analysis predicted that there was a greater than 85% chance of the trial showing statically significant benefit for the psilocybin treatment arm versus the placebo arm at the conclusion of the trial period. Read here: (@Drug_Researcher @Psychedelic_Med @Psyched_Alpha @Psych_Fin @psyinvest)"  
[X Link](https://x.com/ASX_IHL/status/1694504755404616148)  2023-08-24T00:19Z [----] followers, [----] engagements


"$IXHL (#nasdaq) press release: Incannex Completes Dosing and Therapy in Phase [--] "PsiGAD" Clinical Trial Assessing #Psilocybin-assisted Psychotherapy for Generalized Anxiety Disorder; Data Analysis Commences #psychedelics https://www.nasdaq.com/press-release/incannex-completes-dosing-and-therapy-in-phase-2-psigad-clinical-trial-assessing https://www.nasdaq.com/press-release/incannex-completes-dosing-and-therapy-in-phase-2-psigad-clinical-trial-assessing"  
[X Link](https://x.com/anyuser/status/1748105189410873413)  2024-01-18T22:08Z [----] followers, [----] engagements


"$IXHL (#Nasdaq) press release: Incannexs Clarion Clinics Open for Psychedelic-Assisted Treatments NASDAQ https://www.nasdaq.com/press-release/clarion-clinics-open-for-psychedelic-assisted-treatments-2024-02-01 https://www.nasdaq.com/press-release/clarion-clinics-open-for-psychedelic-assisted-treatments-2024-02-01"  
[X Link](https://x.com/ASX_IHL/status/1753144149635998190)  2024-02-01T19:51Z [----] followers, [----] engagements


"#IncannexHealthcare announces a 50:50 joint venture with @MindMedicineAU to operate a psychedelic-assisted therapies services clinic in Melbourne. Read the full press release: #Incannex $IXHL https://bit.ly/4e6IC7f https://bit.ly/4e6IC7f"  
[X Link](https://x.com/anyuser/status/1934937894483054874)  2025-06-17T11:35Z [----] followers, [----] engagements


"#IncannexHealthcare has achieved database lock for the RePOSA Phase [--] #clinicaltrial of IHL-42X the Companys lead drug candidate for #obstructivesleepapnea (OSA). Read the full press release here: #Incannex $IXHL #sleepapnea https://bit.ly/4n9lHMU https://bit.ly/4n9lHMU"  
[X Link](https://x.com/anyuser/status/1935316117641380059)  2025-06-18T12:38Z [----] followers, [----] engagements


"#IncannexHealthcare announces the appointment of Douglas B. Kirsch M.D. FAAN FAASM to its IHL-42X #ObstructiveSleepApnea (OSA) Clinical Advisory Board. Read more: $IXHL #SleepApnea https://bit.ly/3T2WAh1 https://bit.ly/3T2WAh1"  
[X Link](https://x.com/ASX_IHL/status/1937476216426275203)  2025-06-24T11:41Z [----] followers, [----] engagements


"$IXHL CMO Lou Barbato M.D. has 25+ years of experience in #clinicaldevelopment regulatory strategy and global medical affairs. Dr. Barbato's #drugdevelopment expertise has contributed to the approval and launches of multiple therapeutics. Learn more: http://incannex.com/about-us http://incannex.com/about-us"  
[X Link](https://x.com/anyuser/status/1940417857072054570)  2025-07-02T14:30Z [----] followers, [----] engagements


"IHL-42X is an oral fixed-dose combination therapy for the treatment #obstructivesleepapnea (OSA). At #IncannexHealthcare we are conducting a global Phase 2/3 #clinicaltrial to evaluate the efficacy and safety of IHL-42X. Learn more: $IXHL #sleepapnea https://bit.ly/44C1HKg https://bit.ly/44C1HKg"  
[X Link](https://x.com/anyuser/status/1942575169631051991)  2025-07-08T13:23Z [----] followers, 11.4K engagements


"Today were featuring #IncannexHealthcares CSO Mark Bleackley Ph.D. With more than two decades of experience in industry and academic research Dr. Bleackley is responsible for R&D strategy and operations at #Incannex. Learn more: $IXHL https://bit.ly/3FNtZt1 https://bit.ly/3FNtZt1"  
[X Link](https://x.com/anyuser/status/1943304762708906232)  2025-07-10T13:42Z [----] followers, 13.4K engagements


"#IncannexHealthcare welcomes collaborations with partners who share our commitment to addressing unmet medical needs and advancing innovative therapeutics for patients. Together we can make a meaningful impact in healthcare. Learn more: $IXHL https://bit.ly/4f9P9yV https://bit.ly/4f9P9yV"  
[X Link](https://x.com/ASX_IHL/status/1945116986544902541)  2025-07-15T13:43Z [----] followers, 19.7K engagements


"#IncannexHealthcare is currently developing IHL-675A an oral fixed-dose combination of a synthetic cannabidiol and hydroxychloroquine sulfate for the treatment of patients with #rheumatoidarthritis (RA). Learn more on our website: $IXHL #IXHL https://bit.ly/3IOuJPv https://bit.ly/3IOuJPv"  
[X Link](https://x.com/anyuser/status/1945825504608874913)  2025-07-17T12:38Z [----] followers, 22.2K engagements


"#IncannexHealthcare is on a mission to leverage smart drug combinations and purposeful partnerships to develop a new standard of care for each of our programs using #cannabinoid combination-based medicines for clinicians and patients. Learn more: $IXHL http://incannex.com/about-us http://incannex.com/about-us"  
[X Link](https://x.com/anyuser/status/1947653472410829254)  2025-07-22T13:42Z [----] followers, 26K engagements


"#IncannexHealthcare is dedicated to developing and delivering innovative medicines for those that have chronic diseases with unmet needs. $IXHL encourages physicians and patients interested in our #investigationaltherapy #clinicaltrials to visit our site: https://bit.ly/4mvpKlJ https://bit.ly/4mvpKlJ"  
[X Link](https://x.com/anyuser/status/1948378868043120829)  2025-07-24T13:44Z [----] followers, 37.2K engagements


"#IncannexHealthcare announces the appointment of Charlene E. Gamaldo M.D. to its IHL-42X #ObstructiveSleepApnea (OSA) Clinical Advisory Board. Read our full press release here: $IXHL #Neurology #IXHL @HopkinsMedicine #SleepApnea https://bit.ly/4m5HVOq https://bit.ly/4m5HVOq"  
[X Link](https://x.com/anyuser/status/1948708635397521666)  2025-07-25T11:35Z [----] followers, 47.2K engagements


"#IncannexHealthcare is excited to share positive topline results from its #RePOSA Phase [--] #clinicaltrial evaluating IHL-42X a novel oral drug candidate for #obstructivesleepapnea (OSA). Read more here: #ClinicalTrials #SleepApnea #Incannex $IXHL #IXHL https://bit.ly/4l7kof8 https://bit.ly/4l7kof8"  
[X Link](https://x.com/anyuser/status/1950528346234011653)  2025-07-30T12:06Z [----] followers, 98.9K engagements


"In response to recent questions it received from a number of its stockholders $IXHL announces that it does not presently intend to use the full capacity available under its at the market offering program (the ATM) in the near-term. Press release here: https://bit.ly/47a6nKd https://bit.ly/47a6nKd"  
[X Link](https://x.com/anyuser/status/1950891163646357931)  2025-07-31T12:07Z [----] followers, 57.8K engagements


"#IncannexHealthcare announces new patient-reported outcome findings from a subset of participants in its #RePOSA Phase [--] #clinicaltrial of IHL-42X for the treatment of #obstructivesleepapnoea (OSA). Read more: $IXHL #ClinicalTrials #IXHL #ClinicalTrials https://bit.ly/4lnBjKG https://bit.ly/4lnBjKG"  
[X Link](https://x.com/anyuser/status/1953790138301264187)  2025-08-08T12:07Z [----] followers, 27.5K engagements


"$IXHL's #RePOSA Phase [--] #clinicaltrial demonstrated clear statistically and clinically significant improvements across multiple key endpoints for patients receiving IHL-42X compared to placebo highlighting its potential to reduce OSA severity. Read more: https://bit.ly/4l7kof8 #IncannexHealthcare is excited to share positive topline results from its #RePOSA Phase [--] #clinicaltrial evaluating IHL-42X a novel oral drug candidate for #obstructivesleepapnea (OSA). Read more here: https://t.co/l0d95y8YtT #ClinicalTrials #SleepApnea #Incannex $IXHL #IXHL https://t.co/kOXbxtnhnS"  
[X Link](https://x.com/anyuser/status/1955652860290723967)  2025-08-13T15:29Z [----] followers, 31.2K engagements


"#IncannexHealthcares IHL-42X #ObstructiveSleepApnea (OSA) #clinicaltrial topline results and overall study were recently covered by @HealioPulm. Check out the full article here: #IXHL #ClinicalTrials $IXHL @GoHealio https://bit.ly/45DO2D1 🗨RePOSA indicates that IHL-42X has the potential option for treating #OSA MarkBleackleyPhDat @ASX_IHL told Healio. https://t.co/o4Ft7WPiCa https://bit.ly/45DO2D1 🗨RePOSA indicates that IHL-42X has the potential option for treating #OSA MarkBleackleyPhDat @ASX_IHL told Healio. https://t.co/o4Ft7WPiCa"  
[X Link](https://x.com/anyuser/status/1957782783444517282)  2025-08-19T12:32Z [----] followers, 27.3K engagements


"#IncannexHealthcare announced that its Board of Directors has authorized a share repurchase program for up to $20 million of $IXHL's outstanding shares of common stock. Read the full press release here: #IXHL https://bit.ly/41hJYXV https://bit.ly/41hJYXV"  
[X Link](https://x.com/anyuser/status/1958862110286643316)  2025-08-22T12:01Z [----] followers, 42.6K engagements


"#IncannexHealthcare is pleased to report positive data from its Phase [--] #clinicaltrial of PSX-001 (formerly Psi-GAD) a psilocybin-assisted #psychotherapy treatment for Generalised Anxiety Disorder (GAD). Read more: $IXHL #ClinicalTrials #IXHL https://bit.ly/4lJZMK8 https://bit.ly/4lJZMK8"  
[X Link](https://x.com/anyuser/status/1960311854129123784)  2025-08-26T12:02Z [----] followers, 53.9K engagements


"Check out @PsychTimes latest coverage of #IncannexHealthcares positive data from its phase [--] #clinicaltrial of PSX-001 a psilocybin-assisted #psychotherapy treatment for generalized anxiety disorder. Read the coverage here: #IXHL #ClinicalTrials $IXHL https://bit.ly/4pcjqld New positive phase [--] data on PSX-001 a psilocybin-assisted psychotherapy treatment for generalized anxiety disorder: Participants treated with PSX-001 achieved statistically significant and clinically meaningful improvements across every key endpoint. https://t.co/veokhjvhlP https://bit.ly/4pcjqld New positive phase [--] data"  
[X Link](https://x.com/anyuser/status/1963218990387413085)  2025-09-03T12:34Z [----] followers, 25.5K engagements


"#IncannexHealthcares President and CEO Joel Latham recently spoke with @GaurVatsala of @InvezzPortal about how despite IHL-42Xs demonstration of tangible benefits for patients the market has to reflect $IXHL's pipeline progress. Read more: #IXHL https://invezz.com/news/2025/09/03/interview-ihl-42x-showing-tangible-benefits-for-patients-but-market-yet-to-reflect-incannexs-pipeline-progress-says-ceo-joel-latham/ https://invezz.com/news/2025/09/03/interview-ihl-42x-showing-tangible-benefits-for-patients-but-market-yet-to-reflect-incannexs-pipeline-progress-says-ceo-joel-latham/"  
[X Link](https://x.com/anyuser/status/1963595454203269217)  2025-09-04T13:30Z [----] followers, 19.8K engagements


"$IXHL's Head of Clinical Operations Natalie May brings 20+ years of experience managing clinical research programs in the #biopharma and #medicaldevice industries. She leads clinical research for #IXHLs product development programs. Learn more here: http://incannex.com/about-us http://incannex.com/about-us"  
[X Link](https://x.com/ASX_IHL/status/1967935903881708023)  2025-09-16T12:57Z [----] followers, 17.7K engagements


"$IXHL's President & CEO Joel Latham spoke with @BenMComer of the Business of Biotech Podcast about developing #cannabinoid and psychedelic combination therapies for #sleepapnea #rheumatoidarthritis and generalized anxiety disorder. Listen here: #IXHL https://www.lifescienceleader.com/doc/cannabinoid-and-psychedelic-combinations-with-incannex-healthcare-s-joel-latham-0001 https://www.lifescienceleader.com/doc/cannabinoid-and-psychedelic-combinations-with-incannex-healthcare-s-joel-latham-0001"  
[X Link](https://x.com/anyuser/status/1970823227841585292)  2025-09-24T12:10Z [----] followers, 14.8K engagements


"$IXHL's President and CEO Joel Latham joined the @Xtalks Life Science Podcast to discuss how #IXHL is advancing #cannabinoid and psychedelic therapies for chronic conditions like #sleepapnea #rheumatoidarthritis and anxiety disorders. Listen here: https://xtalks.com/exploring-the-future-of-cannabinoid-psychedelic-therapies-with-joel-latham-of-incannex-healthcare-episode-226/ https://xtalks.com/exploring-the-future-of-cannabinoid-psychedelic-therapies-with-joel-latham-of-incannex-healthcare-episode-226/"  
[X Link](https://x.com/anyuser/status/1973372577448960468)  2025-10-01T13:01Z [----] followers, 15.1K engagements


"#IncannexHealthcares President and CEO Joel Latham discusses both his and the $IXHL's extreme dedication to finding ways to shorten the path to commercialization for the companys game changing programs Listen to his conversation with @BenMComer here: https://bit.ly/4nAUvXg https://bit.ly/4nAUvXg"  
[X Link](https://x.com/ASX_IHL/status/1973752102909550765)  2025-10-02T14:09Z [----] followers, 19K engagements


"IHL-42X's positive topline results from its Phase [--] #clinicaltrial confirm statistically significant & clinically meaningful improvements across key endpoints reinforcing its potential as a best-in-class therapy for patients. Learn more here: $IXHL https://bit.ly/431cYUu https://bit.ly/431cYUu"  
[X Link](https://x.com/anyuser/status/1975899200513769547)  2025-10-08T12:20Z [----] followers, 29.4K engagements


"$IXHL's CMO Lou Barbato M.D. spoke with @GoHealio about our phase [--] #clinicaltrial of PSX-001 a psilocybin-assisted treatment for generalized anxiety disorder. Read the full Q&A discussion here: https://www.healio.com/news/psychiatry/20251016/qa-psilocybinbased-therapeutic-opens-up-the-mind-to-the-possibility-of-change https://www.healio.com/news/psychiatry/20251016/qa-psilocybinbased-therapeutic-opens-up-the-mind-to-the-possibility-of-change"  
[X Link](https://x.com/anyuser/status/1978894371505230098)  2025-10-16T18:42Z [----] followers, 19.8K engagements


"$IXHL announces that it has received an additional 180-calendar-day extension from the @Nasdaq Stock Market to regain compliance with the minimum bid price requirement. Read more: https://bit.ly/4ov1lgT https://bit.ly/4ov1lgT"  
[X Link](https://x.com/anyuser/status/1980970454862176420)  2025-10-22T12:12Z [----] followers, 17.8K engagements


"Parisa Asvadi PhD has served as VP of Research & Development of #IncannexHealthcare since [----]. Dr. Asvadi is responsible for $IXHL's regulatory activities with a focus on chemistry manufacturing and controls (CMC). Learn more: http://incannex.com/about-us http://incannex.com/about-us"  
[X Link](https://x.com/ASX_IHL/status/1983164015619740131)  2025-10-28T13:28Z [----] followers, [----] engagements


"$IXHL provides a shareholder update highlighting continued progress across clinical regulatory and capital initiatives positioning for sustained long-term growth. Full press release here: https://bit.ly/4qAOaNj https://bit.ly/4qAOaNj"  
[X Link](https://x.com/anyuser/status/1983867461041844292)  2025-10-30T12:03Z [----] followers, 26.7K engagements


"$IXHL is dedicated to developing and delivering innovative medicines for people with chronic diseases and significant unmet needs. We encourage physicians and patients interested in our investigational therapies to review our ongoing #clinicaltrials: https://bit.ly/4mvpKlJ https://bit.ly/4mvpKlJ"  
[X Link](https://x.com/anyuser/status/1986083370070413491)  2025-11-05T14:49Z [----] followers, 12.4K engagements


"$IXHL's President and CEO Joel Latham shares how our team navigates complex global regulatory pathways builds strategic collaborations and forges a path toward commercial success in this article from Drug Development & Delivery. Read the Q&A here: https://drug-dev.com/expert-content/executive-interview-incannex-healthcare-pioneering-the-future-of-cannabinoid-and-psychedelic-therapies/ https://drug-dev.com/expert-content/executive-interview-incannex-healthcare-pioneering-the-future-of-cannabinoid-and-psychedelic-therapies/"  
[X Link](https://x.com/anyuser/status/1987895643671785734)  2025-11-10T14:50Z [----] followers, 10.9K engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing